AK-106 (AK106-001616) is a selective cytosolic phospholipase A2 (cPLA2) inhibitor. It exhibits analgesic effects comparable to NSAIDs and is utilized in research to study inflammatory pathways, with applications in both in vitro biochemical assays and in vivo models of pain and inflammation.
Molecular Weight:
427.49
CAS Number:
[590416-75-4]
Formula:
C26H25N3O3
Target:
Others,Phospholipase
* VAT and and shipping costs not included. Errors and price changes excepted